GSK's shares were hit last week by investor concerns about the litigation around potential cancer-causing impurities that prompted the drug's withdrawal from markets in 2019 and 2020.
(Reporting by Leroy Leo in Bengaluru; Editing by Aditya Soni)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,640 GBX | +0.28% | +3.60% | +13.12% |
07:58pm | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
07:00pm | GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines | MT |
(Reuters) - GlaxoSmithKline Plc said on Tuesday that plaintiffs in the first scheduled U.S. lawsuit around heartburn drug Zantac will file a notice to voluntarily dismiss the case.
GSK's shares were hit last week by investor concerns about the litigation around potential cancer-causing impurities that prompted the drug's withdrawal from markets in 2019 and 2020.
(Reporting by Leroy Leo in Bengaluru; Editing by Aditya Soni)
1st Jan change | Capi. | |
---|---|---|
+13.12% | 83.1B | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |